AI Vivo
PrivateLast Round
Grant
Mar 24, 2026
Total Funding Raised
$103,000
Company Overview
AI Vivo operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in March 2026.
AI Vivo is a biotechnology company that develops an AI-based proprietary pharmacology platform designed to capture the dynamic effect of diseases and treatments at the organ level to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AI Vivo Comparables
Compare AI Vivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 87% | |
| Pathway Bio | 86% | |
| CytoReason | 86% |
For institutional investors. Book with your work email.
AI Vivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 24, 2026 | ||||
| Accelerator | Nov 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AI Vivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Seed |
| KQ Labs | Accelerator |
| Acequia Capital | Seed |
| o2h ventures | Seed |
| The Francis Crick Institute | Accelerator |
| LifeArc | Accelerator |
| Martlet Capital | Seed |
For institutional investors. Book with your work email.
AI Vivo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AI Vivo's valuation, stock price, and market status.
Is AI Vivo a public or private company?
AI Vivo is a private company.
What is the current stock price of AI Vivo?
AI Vivo is a private company, so its shares have no public market price. Caplight tracks AI Vivo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AI Vivo worth (valuation)?
Valuation information for AI Vivo is not publicly available.
Can I buy AI Vivo stock?
AI Vivo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AI Vivo's last funding round?
AI Vivo's most recent funding round was Grant on March 24, 2026.
Who are the main investors in AI Vivo?
Key investors in AI Vivo include Amadeus Capital Partners, KQ Labs, Acequia Capital, o2h ventures, The Francis Crick Institute.
Will AI Vivo IPO soon?
No public IPO plans have been announced for AI Vivo.
How can I track AI Vivo secondary market activity?
Caplight tracks bids, offers, and trades in AI Vivo's shares on secondary markets.